Our findings show that S100A4 has a role in ALS-related mechanisms, and that drugs such as niclosamide which are able to target inflammatory and fibrotic pathways could represent promising pharmacological tools for ALS. This evidence concerns the gene S100A4 and amyotrophic lateral sclerosis.